Rheumatology Treatment

Until recently most rheumatic diseases were treated with analgesics, NSAIDs (Non-Steroid Anti-Inflammatory Drugs), steroids (in serious cases) and oral DMARDs (Disease-Modifying Anti-Rheumatic Drugs) but advances in management has seen use of monoclonal antibodies, such as infliximab and adalimumab for moderate to severe Rheumatoid arthritis. Other biologic like IL6 inhibitors and  Rituximab (Anti-B-Cell Therapy) is now licensed for use in refractory Rheumatoid Arthritis.

Patients with rheumatoid arthritis often need a long term, coordinated and a multidisciplinary team approach towards management of individual patients, treatment is often tailored according the individual needs of the patient which is also dependent on the response and the tolerability of medications.